Submission Details
| 510(k) Number | K230997 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | April 07, 2023 |
| Decision Date | December 28, 2023 |
| Days to Decision | 265 days |
| Submission Type | Traditional |
| Review Panel | Neurology (NE) |
| Summary | Summary PDF |
K230997 is an FDA 510(k) clearance for the EvoWalk 1.0 System, a Stimulator, Neuromuscular, External Functional (Class II — Special Controls, product code GZI), submitted by Evolution Devices, Inc. (Oakland, US). The FDA issued a Cleared decision on December 28, 2023, 265 days after receiving the submission on April 7, 2023. This device falls under the Neurology review panel. Regulated under 21 CFR 882.5810.
| 510(k) Number | K230997 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | April 07, 2023 |
| Decision Date | December 28, 2023 |
| Days to Decision | 265 days |
| Submission Type | Traditional |
| Review Panel | Neurology (NE) |
| Summary | Summary PDF |
| Product Code | GZI — Stimulator, Neuromuscular, External Functional |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 882.5810 |